Biotechnology and pharmaceutical companies seeking to train employees, or even to create their own "online university" can now partner with The Pharmaceutical Institute (PI, Raleigh, NC, www.pharmainstitute.com).
Biotechnology and pharmaceutical companies seeking to train employees, or even to create their own “online university” can now partner with The Pharmaceutical Institute (PI) of Raleigh, NC (www.pharmainstitute.com). PI, a subsidiary of the consulting firm Campbell Alliance, launched its “Corporate Academy Program” in June. The program allows industry clients to implement a training infrastructure without having to set up their own learning management system (LMS).
“We realized there are a lot of small companies or work groups within large companies that have an interest in training, but they don’t have the resources to commit to evaluating, purchasing, and implementing an LMS, maintaining that system, developing new content, or going out and surveying the universe of available content and keep it running for their employees,” said Dan Blue, executive director of PI. “We can set it all up for them with a turn-key solution that allows users to get up and running fairly quickly.”
Clients have the option of using their own proprietary educational material, using PI’s resources, using material licensed by PI from outside vendors, or any combination of all three to customize an educational program for employees.
Services available include:
Although the system originally was designed for small- to mid-size companies, Craig Dunkley, vice president of marketing for Campbell Alliance, says the program’s flexibility also makes it suitable for work groups within large corporations. “If individual work groups within [a large pharmaceutical] company come to us and want to work on developing a corporate academy, we’re certainly happy to do that,” he said.
Cost to the client for participating in the Corporate Academy Program is determined by the number of participants and the amount of educational content, per the terms of each individual agreement.
–Pam Holland-Moritz
The Future of Cleanroom Construction: How Hybrid Solutions are Changing the Game
May 14th 2025Imagine a world where cleanroom facilities—essential for pharmaceutical manufacturing, biotechnology, and high-tech industries—are built with unparalleled speed, precision, and efficiency. That world is here, thanks to the hybrid construction approach. By blending traditional stick-built methods with modular and prefabricated solutions, companies are overcoming the limitations of conventional construction while ensuring compliance with stringent industry regulations. In this interview, we explore how hybrid cleanroom construction is transforming the industry, offering faster project timelines, improved quality control, and significant cost advantages. Join us as we delve into this game-changing approach with industry experts who are leading the charge in revolutionizing cleanroom infrastructure.
Mastering Antibody-Drug Conjugates
December 19th 2024In this episode, we explore BIOVECTRA’s capabilities in antibody-drug conjugate (ADC) manufacturing, from complex conjugation chemistry to synthesis of highly potent payloads. We’ll also showcase how BIOVECTRA’s extensive experience in complex chemistries and specialized small molecule manufacturing gives them a unique perspective, strengthening their approach to ADC production and ensuring clients receive custom solutions across all project stages.
Kyron.bio Raises €5.5M to Advance Precision Glycan Engineering for Safer Antibody Therapeutics
May 28th 2025Funding will support the company’s efforts to refine its proprietary glycan-engineering platform, expand its scientific and operational team, and advance preclinical studies of its engineered biologics.